| Announce Date | 10/21/2025 |
| EPS Normalized Actual | $1.19 (Beat by $0.08) |
| EPS GAAP Actual | $1.19 (Beat by $0.08) |
| Revenue Actual | $0.235651B |
| Revenue Surprise | Beat by $235.651M |
| Announce Date | 10/01/2025 (Pre-Market) |
| EPS Normalized Estimate | $1.32292 |
| EPS GAAP Estimate | $1.32292 |
| Revenue Estimate | $0.235792061B |
| Fiscal Period Ending | EPS Estimate | Forward PE | Low | High | # of Analysts |
|---|---|---|---|---|---|
| Dec 2029 | 7.44 | 24.47 | 7.28535 | 7.63995 | 1 |
| Dec 2028 | 6.2 | 29.36 | 5.98464 | 6.56443 | 1 |
| Period | EPS | Beat / Miss | Revenue | YoY | Beat / Miss |
|---|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.19 | -0.0684 | 0.235651B | 11.55% | 8.92M |
| FQ2 2025 (Jun 2025) | 1.17 | 0.20256 | 0.238095B | 9% | 34.58M |
| FQ1 2025 (Mar 2025) | 1.31 | 1.31 | 0.222211B | 11.67% | 222.21M |
| FQ4 2024 (Dec 2024) | 1.05 | 1.05 | 0.205182B | 11.08% | 205.18M |
| FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 0.208438B | 10.67% | 208.44M |
| FQ2 2024 (Jun 2024) | 1.13 | 1.13 | 0.216658B | 18.83% | 216.66M |
| FQ1 2024 (Mar 2024) | 0.99 | 0.99 | 0.19628B | 18.94% | 196.28M |
| FQ4 2023 (Dec 2023) | 0.84 | 0.84 | 0.18244B | 19.25% | 182.44M |
FQ4 Announce Date
10/01/2025 (Pre-Market)
Consensus EPS Estimates
1.32292
Consensus Revenue Estimates
0.235792061B
| Fiscal Period Ending | EPS Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 1.38074 | -- | 1.33374 | 1.43711 | 5 |
| FQ3 2027 (Sep 2027) | 1.53893 | -- | 1.48357 | 1.57494 | 1 |
| FQ2 2027 (Jun 2027) | 1.51947 | -- | 1.46481 | 1.55503 | 1 |
| FQ1 2027 (Mar 2027) | 1.37125 | -- | 1.34586 | 1.39128 | 1 |
| FQ4 2026 (Oct 2026) | 1.2467 | -- | 1.21397 | 1.31798 | 0 |
| FQ3 2026 (Jul 2026) | 1.25021 | 4.82 | 1.21738 | 1.32169 | 0 |
| FQ2 2026 (Jun 2026) | 1.13864 | -2.75 | 1.06307 | 1.18169 | 1 |
| FQ1 2026 (Mar 2026) | 1.07557 | -21.8 | 1.00419 | 1.11623 | 1 |
| Fiscal Period Ending | Revenue Estimate | YoY Growth(%) | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2027 (Dec 2027) | 0.26B | -- | 0.25B | 0.26B | 3 |
| FQ3 2027 (Sep 2027) | 0.29B | -- | 0.28B | 0.29B | 2 |
| FQ2 2027 (Jun 2027) | 0.28B | -- | 0.27B | 0.28B | 2 |
| FQ1 2027 (Mar 2027) | 0.27B | -- | 0.26B | 0.27B | 2 |
| FQ4 2026 (Oct 2026) | 0.24B | -- | 0.23B | 0.25B | 1 |
| FQ3 2026 (Jul 2026) | 0.23B | -1.36 | 0.23B | 0.24B | 1 |
| FQ2 2026 (Jun 2026) | 0.22B | -6.83 | 0.21B | 0.23B | 2 |
| FQ1 2026 (Mar 2026) | 0.22B | -1.81 | 0.21B | 0.22B | 2 |
EPS # of Up Revisions
4
EPS # of Down Revisions
4
Revenue # of Up Revisions
6
Revenue # of Down Revisions
3
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
| Fiscal Period Ending | EPS Estimate | YoY Growth | Low | High | # of Analysts |
|---|---|---|---|---|---|
| FQ4 2021 (Dec 2021) | 0.41 | -12.52% | 0.39 | 0.48 | 20 |
| FQ1 2022 (Mar 2022) | 0.59 | 6.89% | 0.55 | 0.62 | 15 |
| FQ2 2022 (Jun 2022) | 0.70 | 2.62% | 0.61 | 0.74 | 15 |
| FQ3 2022 (Sep 2022) | 0.68 | 4.62% | 0.65 | 0.70 | 15 |
EPS # of Beats
7
EPS # of Misses
1
EPS # of in-lines
0
Revenue # of Beats
8
Revenue # of Misses
0
Revenue # of in-lines
0
| Earnings Date | EPS Estimate | EPS Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | 1.2584 | 1.19 | -0.0684 | -5.75% |
| FQ2 2025 (Jun 2025) | 0.96744 | 1.17 | 0.20256 | 17.31% |
| FQ1 2025 (Mar 2025) | 1.31 | 1.31 | 100% | |
| FQ4 2024 (Dec 2024) | 1.05 | 1.05 | 100% | |
| FQ3 2024 (Sep 2024) | 1.09 | 1.09 | 100% | |
| FQ2 2024 (Jun 2024) | 1.13 | 1.13 | 100% | |
| FQ1 2024 (Mar 2024) | 0.99 | 0.99 | 100% | |
| FQ4 2023 (Dec 2023) | 0.84 | 0.84 | 100% |
| Earnings Date | Revenue Estimate | Revenue Actual | Surprise | Surprise % |
|---|---|---|---|---|
| FQ3 2025 (Sep 2025) | $0.23B | $0.24B | $8.92M | 3.79% |
| FQ2 2025 (Jun 2025) | $0.2B | $0.24B | $34.58M | 14.52% |
| FQ1 2025 (Mar 2025) | $0B | $0.22B | $222.21M | 100% |
| FQ4 2024 (Dec 2024) | $0B | $0.21B | $205.18M | 100% |
| FQ3 2024 (Sep 2024) | $0B | $0.21B | $208.44M | 100% |
| FQ2 2024 (Jun 2024) | $0B | $0.22B | $216.66M | 100% |
| FQ1 2024 (Mar 2024) | $0B | $0.2B | $196.28M | 100% |
| FQ4 2023 (Dec 2023) | $0B | $0.18B | $182.44M | 100% |